About Us

  • Mission

    We incubate companies at the convergence of groundbreaking technologies and innovative science,

    bringing transformative medicines and solutions to the global market.



    ABIO-X at a Glance 

    ABIO-X, backed by CBC group, will have wholly-owned subsidiaries and invest in certain controlled companies

    which will each have its own product portfolio and operations managed by a separate leadership team. A decentralized structure allows focus at the subsidiary level while maintaining support

    services from the parent holding company.